CVS News 73.74 CVS Corp (CVS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
CVS Corp (CVS) 73.74 $CVS

1 Strategy That May Allow Walgreen to Surpass CVS and Crush Rite Aid
Daniel Jones, The Motley Fool - Motley Fool - Sat Apr 19, 9:00AM CDT
Source: Wikimedia Commons On April 14, news broke that a group of investors who control about 5% of Walgreen 's shares met in Paris last Friday to discuss the benefits of the business engaging in a tax inversion. By doing this type of...

Rite Aid Is on the Right Track
Daniel James, The Motley Fool - Motley Fool - Fri Apr 18, 3:00PM CDT
For years, Rite Aid , America's third-largest drugstore chain, has been locked in a struggle for survival as larger rivals Walgreen and CVS Caremark aggressively expanded their footprints. In fact, Rite Aid posted a loss in every year between...

CVS Caremark Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 5:55PM CDT
CVS has delivered positive earnings surprises in all of the last 4 quarters with an average beat of 3.5%.

3 Reasons Rite Aid Continues to Crush the Market
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 17, 5:30PM CDT
It's rare for struggling retailers to come back from the brink, but that's exactly what has happened at Rite Aid . Shares in the east and west coast pharmacy operator traded below $1 as mounting losses threatened its survival just a few years ago....

Sozzi: Jelly Belly Is an Easter Treat for Market Watchers
at The Street - Thu Apr 17, 9:00AM CDT
Ahead of Easter, the second-largest holiday for the industry behind Halloween, we had the opportunity to talk with jelly bean king Jelly Belly's Vice President of Marketing Rob Swaigen about the company's new products.

Will Walgreens Relocate to Europe? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 2:20PM CDT
Walgreens has been pressurized by an influential group of its investors to relocate itself to Europe.

Earnings Roundup: Rite Aid Impresses
Todd Campbell, The Motley Fool - Motley Fool - Tue Apr 15, 5:00PM CDT
Rite Aid has been an investment darling over the past year as it continues to boost its profitability and play catch-up to competitors CVS Corp. and Walgreen . Shares in Rite Aid have more than doubled since last fall thanks to an aggressive...

Rite Aid Upped to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 4:35PM CDT
Rite Aid has been witnessing rising earnings estimates on the back of better-than-expected fourth-quarter fiscal 2014 results and it provided an impressive guidance for fiscal 2015.

Is Dollar General Worth Your Dollars?
Zahid Waheed, The Motley Fool - Motley Fool - Tue Apr 15, 9:00AM CDT
Dollar General  is among the few retailers which were able to post strong results during this season. Let's see how the company has been able to achieve these results and how it's performing in relation to its peers  Big Lots and Dollar Tree...

'Fast Money' Recap: Long on Financials
at The Street - Tue Apr 15, 4:00AM CDT
The trading panel discussed Citigroup's earnings and Google's drone company purchase.

CVS Caremark (CVS) Breaks Through Resistance at $73.08
Comtex SmarTrend(R) - Mon Apr 14, 11:44AM CDT
Shares of CVS Caremark (NYSE:CVS) opened today above their pivot of $72.72 and have already reached the first level of resistance at $73.08. Investors may be interested in a cross of the next upside pivot targets of $73.57 and $74.42.

How Much Is Rite Aid’s Stock Worth?
Brian Nichols, The Motley Fool - Motley Fool - Mon Apr 14, 9:00AM CDT
Rite Aid soared to 13-year highs after it reported fourth-quarter earnings that exceeded expectations and issued bullish guidance for the upcoming year. As a result, Rite Aid's stock price has now risen by almost 500% since 2012. While considering...

Critical Alerts For Prudential, SanDisk, 3M, Bed Bath & Beyond, and CVS Caremark Released By InvestorsObserver
PR Newswire - Mon Apr 14, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for PRU, SNDK, MMM, BBBY, and CVS.

Is Rite Aid Gonna Go CVS on Us?
Daniel Jones, The Motley Fool - Motley Fool - Mon Apr 14, 7:30AM CDT
Source: Wikimedia Commons.  After news that Rite Aid , the world's third largest publicly traded drugstore chain, had smashed both revenue and earnings forecasts, shares of the company soared more than 8%. The news was also accompanied by a rosy...

Is Rite Aid a Likely Acquisition Target?
Brian Nichols, The Motley Fool - Motley Fool - Sat Apr 12, 8:05AM CDT
Rite Aid has been at the center of acquisition rumors for years, even before its epic return to profitability. As a business on the rebound with new-found year-over-year revenue growth, Walgreen or CVS might find it attractive. However, if...

Could the Drugstore Giants See Some Value at Fred's?
Robert Hanley, The Motley Fool - Motley Fool - Sat Apr 12, 6:30AM CDT
                               Discount retailer Fred's has been taking a page from the drugstore giants' playbooks in a bid to transform itself into a health care-focused retailer of pharmaceuticals and related personal care products. The...

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Apr 11, 7:09PM CDT
This was a week to forget, Cramer says. But it's still earnings season and here's what he'll be watching.

The Healthcare Clinic at Eva's Village Awarded $35,000 Grant by CVS Caremark Charitable Trust in Partnership With the National Association of Free & Charitable Clinics
PRWeb - Fri Apr 11, 11:41AM CDT
The Healthcare Clinic at Eva's Village announced it has received a grant from the CVS Caremark Charitable Trust, a private foundation created by CVS Caremark Corporation in partnership with the National Association of Free & Charitable Clinics (NAFC). The $35,000 grant has been awarded to The Healthcare Clinic at Eva's Village as part of the CVS Caremark Charitable Trust's commitment to help support community health and expand access to quality health care.

Rite Aid Reaches 52-Week High on Q4 Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:00AM CDT
Rite Aid posted better-than-expected fourth-quarter fiscal 2014 results.

Industry Reports, Partnerships, Grants, Upcoming Events, and App Launches - Analyst Notes on eBay, The Home Depot, CVS Caremark, Chipotle Mexican, and Expedia
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding eBay Inc. (NASDAQ: EBAY), The Home Depot, Inc. (NYSE: HD), CVS Caremark Corporation (NYSE: CVS), Chipotle Mexican Grill, Inc. (NYSE: CMG), and Expedia Inc. (NASDAQ: EXPE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Daqo New Energy Faces Key Investor Meeting in December

Updated Category News Views 88

Spotlight on December's Agenda for Daqo Shareholders Who'd have thought we'd be looking at another year end with the same burning energy interests? Daqo New Energy Corp. (NYSE: DQ) is setting up for its annual general meeting (AGM) dated December 10, 2026. Mark your calendars, because these gatherings can be more than just straightforward affairs; sometimes they reveal...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 7

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 41

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 19

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Dawson Struggles With Q3 Losses Despite Growth Prospects

Updated Category News Views 42

Profit and loss dance around like a jittery stock, and Dawson Geophysical is feeling the heat this third quarter. Numbers are in, and we’re seeing a net loss of $5.2 million, translating to $0.17 per share—ouch. Not to mention a negative Adjusted EBITDA of $2 million. Compared to last year's hopes, that's a serious belly flop. Revenue Down, Hopes Up In a fetching...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 114

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
DarioHealth's New Research Tackles Healthcare Cost Estimation

Updated Category News Views 91

Unpacking Dario's Bold Surgical Strike at ISPOR Europe Alright, folks, DarioHealth is shaking up the stage with their new methodology that could very well carve a new path in how we size up digital healthcare savings. Presented at ISPOR Europe 2026, Dario's tactic bypasses the sluggish wait on medical claims data, instead offering an evidence-driven peek at potential...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 136

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading

Top 5 Most Recently Viewed Articles

Piper Sandler Welcomes John Kerins to Healthcare Team

Updated Category News Views 218

Piper Sandler Expands Healthcare Investment Banking Expertise Piper Sandler Companies (NYSE: PIPR), a prominent name in investment banking, is excited to announce a significant addition to their healthcare investment banking team with the hiring of John Kerins as a managing director. This strategic move reflects the firm’s commitment to strengthening its presence in the...

Continue Reading
Exploring North America's Last Mile Delivery Growth and Trends

Updated Category News Views 346

Exploring North America's Last Mile Delivery Growth and Trends The last mile delivery market in North America is poised for significant growth over the next few years. Experts estimate that this market could expand by USD 14.9 billion between 2025 and 2029. This impressive growth is being driven primarily by the increasing demand for business-to-consumer (B2C) e-commerce....

Continue Reading
Mastercard Marks 20 Years on NYSE with Digital Shift

Updated Category News Views 39

A Landmark Moment at the NYSE for Mastercard Ah, another day in the whirlwind of the stock universe, where birthdays are celebrated with the finesse of boardroom discussions. Mastercard (NYSE: MA) is taking a well-deserved spotlight as it cheers two decades since it hit the seal of the New York Stock Exchange. Back on May 26th, it wasn't just business as usual. Nope, they...

Continue Reading
Insights into the Expanding Network of China-Europe Freight Trains

Updated Category News Views 236

The Rise of China-Europe Freight Trains Recently, a significant milestone was reached when the 110,000th China-Europe freight train departed from Jiaozhou Station, fully loaded with various goods such as electronic displays and household appliances. This service has now transported goods worth over USD 450 billion, showcasing its crucial role in global trade. The Journey...

Continue Reading
Netflix Investors Encouraged to Report Losses Amid Investigation

Updated Category News Views 217

Investigation Focus on Netflix, Inc. (NASDAQ: NFLX) Recently, significant scrutiny has emerged surrounding Netflix, Inc. (NASDAQ: NFLX), as Edelson Lechtzin LLP, a prominent national law firm known for handling class action lawsuits, initiates an investigation into potential violations of federal securities laws. This inquiry seeks to determine whether Netflix and certain...

Continue Reading